Source:http://linkedlifedata.com/resource/pubmed/id/20186829
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
8
|
pubmed:dateCreated |
2010-4-14
|
pubmed:abstractText |
The short-term provision of ghrelin to patients with cancer indicates that there may be benefits from long-term provision of ghrelin for the palliative treatment of weight-losing cancer patients. This hypothesis was evaluated in a randomized, double-blind, phase 2 study.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
0008-543X
|
pubmed:author | |
pubmed:copyrightInfo |
(c) 2010 American Cancer Society.
|
pubmed:issnType |
Print
|
pubmed:day |
15
|
pubmed:volume |
116
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
2044-52
|
pubmed:meshHeading |
pubmed-meshheading:20186829-Aged,
pubmed-meshheading:20186829-Appetite Stimulants,
pubmed-meshheading:20186829-Double-Blind Method,
pubmed-meshheading:20186829-Female,
pubmed-meshheading:20186829-Gastrointestinal Neoplasms,
pubmed-meshheading:20186829-Ghrelin,
pubmed-meshheading:20186829-Humans,
pubmed-meshheading:20186829-Male,
pubmed-meshheading:20186829-Motor Activity,
pubmed-meshheading:20186829-Quality of Life,
pubmed-meshheading:20186829-Weight Loss
|
pubmed:year |
2010
|
pubmed:articleTitle |
Effects by daily long term provision of ghrelin to unselected weight-losing cancer patients: a randomized double-blind study.
|
pubmed:affiliation |
Department of Surgery, Surgical Metabolic Research Laboratory at Lundberg Laboratory for Cancer Research, Sahlgrenska Academy and University Hospital, Gothenburg, Sweden. kent.lundholm@surgery.gu.se
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|